Chronic myelogenous leukemia. Correlation between clinical, laboratory and cytogenetic data
Lisker, R.; Pérez-Chávez, F.; Casas, L.; Córdova, M.S.; Mutchinick, O.
Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 32(2): 187-192
1980
ISSN/ISBN: 0034-8376 PMID: 6932688 Document Number: 155762
Document emailed within 1 workday
Related Documents
Aurer, I.; Canaani, E.; Gale, R.P. 1991: Hypothesis: additional cytogenetic abnormalities and progression to acute phase in chronic myelogenous leukemia Leukemia 5(11): 1012-1013Usman, M.; Kakepoto, G.N.; Adil, S.N.; Sajid, R.; Arain, S.; Khurshid, M. 2004: Hematologic and cytogenetic findings in eleven chronic myelogenous leukemia patients treated with imatinib mesylate at a tertiary care hospital Jpma. Journal of the Pakistan Medical Association 54(1): 17-20
Talpaz, M.; Kantarjian, H.; Kurzrock, R.; Gutterman, J.U. 1989: Clinical studies with interferons in Philadelphia positive chronic myelogenous leukemia Bone Marrow Transplantation 4(Suppl 1): 63
Ishibashi, T.; Abe, R.; Kimura, H.; Shichishima, T.; Matsuda, S.; Uchida, T.; Kariyone, S. 1985: Involvement of eosinophils in leukemic clones: cytogenetic study in eosinophilic colonies from acute myelogenous leukemia associated with 8;21 translocation Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(5): 1161-1167
Sherman, S.I.; Abdulkadyrov, K.M.; Shandlorenko, S.K.; Kuraleva, V.V. 1979: Clinical morphological, cytogenetic and genealogical studies of patients with chronic monocytic leukemia Voprosy Onkologii 25(1): 38-43
Opalka, B.; Wandl, U.; Beer, U.; Roggenbuck, U.; Kloke, O.; Niederle, N. 1991: Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapy Leukemia 5(6): 452-456
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
Dhingra, K.; Talpaz, M.; Kantarjian, H.; Ku, S.; Rothberg, J.; Gutterman, J.U.; Kurzrock, R. 1991: Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression Leukemia 5(3): 191-195
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596
Shumak, K.H.; Baker, M.A.; Taub, R.N.; Coleman, M.S. 1980: Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 40(11): 4048-4052
Mori, M. 2001: Laboratory features of acute myelogenous leukemia in elderly patients Rinsho Byori. Japanese Journal of Clinical Pathology 49(5): 433-437
Döhner, H.; Stilgenbauer, S.; Fischer, K.; Bentz, M.; Lichter, P. 1997: Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes Leukemia 11(Suppl): S19-S24
Anderson, J.K.; Moore, J.O.; Metzgar, R.S. 1979: Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 39(12): 4810-4815
Calandi, C.; Adami Lami Conti, C.; Fronzoni, S.; Nistri, R.; Rossini, F.; Aulisi, A. 1980: Xeroradiographic examination in the study of Duchenne's progressive muscular dystrophy. Correlation of the radiological data with the clinical and laboratory findings Minerva Pediatrica 32(5): 283-289
Alsabti, E.A.; Taleb, A.M.; Raji, H.M.; Kalil, O.Z.; Saleh, K.A. 1979: Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia Japanese Journal of Experimental Medicine 49(3): 157-168
Tsuji-Takayama, K.; Kamiya, T.; Nakamura, S.; Matsuo, Y.; Adachi, T.; Tsubota, T.; Imanishi, J.; Minowada, J. 1994: Establishment of multiple leukemia cell lines with diverse myeloid and/or megakaryoblastoid characteristics from a single Ph1 positive chronic myelogenous leukemia blood sample Human Cell 7(3): 167-171
Nawata, R.; Shinohara, K.; Yamada, T.; Takahashi, T.; Katsuki, K.; Takeda, K.; Kameda, N.; Ariyoshi, K.; Ota, I.; Muraki, K. 2000: Morphological and cytogenetic changes in therapy-related leukemia developed in a t(8;21)-acute myeloid leukemia (M2) patient: sequential cytogenetic and molecular analyses International Journal of Hematology 71(4): 353-358
Guilhot, F. 1994: The role of interferon in the treatment of chronic myelogenous leukemia in chronic phase Nouvelle Revue Francaise d'Hematologie 36(Suppl 1): S39-S46
Gao, J.S.; Zhang, G.R.; Zhu, B.X.; Xu, M.Y.; Xue, Y.Q.; Shao, J.Z.; He, Z.X.; Hu, Z.D. 1987: Clinical classification of 109 chronic myeloid leukemia cases and its correlation with Ph chromosomes Chinese Medical Journal 100(4): 333-334
Airoldi, M.; Colombo, A.; Fantasia, R.; Colombo, G.; Gobbi, A. 1989: Chronic T-cell lymphocytic leukemia: clinical and laboratory aspects of 5 patients Recenti Progressi in Medicina 80(6): 293-296